Collection of Human Metabolic Tissues (COMET)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02861781 |
Recruitment Status : Unknown
Verified January 2020 by University Hospital, Montpellier.
Recruitment status was: Recruiting
First Posted : August 10, 2016
Last Update Posted : January 9, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
This project aims at identifying new determinants of type 2 diabetes in severe obesity. To do so, a biological collection, including tissues of interest in the field of metabolism, will be collected during bariatric surgery in obese patients. Three different groups of metabolic status of patients, corresponding to different stages of evolution of the disease, will be constituted: type 2 diabetes, insulin resistance, insulin sensitivity.
The main objective is to compare, between these 3 groups of patients, several biological processes that may be involved in the pathophysiology of type 2 diabetes and disorders associated with obesity, including:
- Abnormalities of the transcriptome, proteome, metabolome in all target tissues (plasma, serum, muscle, subcutaneous and visceral adipose tissue, omental artery, liver)
- Identification of metabolic signatures, protein and miRNA in plasma
- Immunoinflammatory response in adipose tissue
- Polymorphisms SNP from whole blood
- Histological analysis of tissue sections This main objective will be studied on samples taken at the time of surgery Secondary objectives will be to study the changes in metabolites, proteins and miRNA in plasma level 3 and 12 months after the completion of surgery, according to the initial metabolic state.
Condition or disease | Intervention/treatment |
---|---|
Obesity Insulin Resistance Diabetes Mellitus, Type 2 | Other: Collection of blood samples and tissues |
Study Type : | Observational |
Estimated Enrollment : | 270 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Study of New Determinants of Type 2 Diabetes in Severe Obesity |
Actual Study Start Date : | February 2, 2016 |
Estimated Primary Completion Date : | September 2020 |
Estimated Study Completion Date : | September 2022 |

Group/Cohort | Intervention/treatment |
---|---|
Type 2 diabetes
Type 2 diabetes according to ADA criteria
|
Other: Collection of blood samples and tissues
Collection of blood samples and tissues during bariatric surgery and blood samples during followup visits |
Insulin resistance non diabetes
HOMA-IR criteria ≥ 3
|
Other: Collection of blood samples and tissues
Collection of blood samples and tissues during bariatric surgery and blood samples during followup visits |
Insulin sensitivity non diabetes
HOMA-IR criteria < 3
|
Other: Collection of blood samples and tissues
Collection of blood samples and tissues during bariatric surgery and blood samples during followup visits |
- comparison of metabolites [ Time Frame: At baseline (day of surgery) ]
- comparison of proteins levels [ Time Frame: At baseline (day of surgery) ]in liver, muscle, adipose tissue and plasma according to metabolic state
- comparison of miRNA [ Time Frame: At baseline (day of surgery) ]in liver, muscle, adipose tissue and plasma according to metabolic state
- changes in metabolites in plasma level [ Time Frame: 3 and 12 months after the completion of surgery ]
- changes in proteins in plasma level [ Time Frame: 3 and 12 months after the completion of surgery ]
- changes in miRNA in plasma level [ Time Frame: 3 and 12 months after the completion of surgery ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Written informed consent
- Age 18 - 65 years inclusive at surgery
- IMC > 35
- Subject qualified for bariatric surgery (sleeve gastrectomy or gastric bypass)
-
Specific criteria :
- Type 2 diabetes group (D) (90 patients) : type 2 diabetes according to ADA criteria
- Insulin resistance non diabetes group (IR) (80 patients) : HOMA-IR criteria ≥ 3
- Insulin Sensitivity non diabetes group (N) (100 patients) : N1.HOMA-IR criteria < 3
Non inclusion Criteria:
- Vulnerability according to article L1121-6 of the Public Health Code
- Protected adult or unability to give consent according to article L1121-8 of the Public Health Code
- Unability to understand the design and aims of the study or to communicate with the investigator
- Non affiliation to a social security system
- Prior bariatric surgery (except lap-band procedure)
- Serologic profile indicating hepatitis B, hepatitis C or HIV infection
- Inflammatory, infectious or autoimmune disease (current or in the previous 3 month)
- Malignancies within 5 years prior to inclusion or not considered as treated curatively
- Concomitant use of steroids or NSAI or use in the 8 days before surgery
- alcohol abuse/addiction
- Anticipated poor compliance to study procedures
- Other type of diabetes than type 2
Exclusion Criteria :
- Cancelled bariatric surgery
- Tissue collection not possible during the bariatric surgery

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02861781
Contact: Florence Galtier, MD | f-galtier@chu-montpellier.fr |
France | |
Hôpital Saint Eloi | Recruiting |
Montpellier, France, 34295 | |
Contact: Florence Galtier, MD f-galtier@chu-montpellier.fr | |
Principal Investigator: Florence Galtier, MD |
Principal Investigator: | Florence GALTIER | Montpellier University Hospital |
Responsible Party: | University Hospital, Montpellier |
ClinicalTrials.gov Identifier: | NCT02861781 |
Other Study ID Numbers: |
RECHMPL15_0271 2015-A01193-46 ( Other Identifier: French Agency for the Safety of Health Products ) UF 9605 ( Other Identifier: Montpellier University Hospital ) |
First Posted: | August 10, 2016 Key Record Dates |
Last Update Posted: | January 9, 2020 |
Last Verified: | January 2020 |
Bariatric surgery |
Obesity Diabetes Mellitus, Type 2 Insulin Resistance Overnutrition Nutrition Disorders Overweight |
Body Weight Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Hyperinsulinism |